Migraine-associated vestibulopathy.
OBJECTIVE
In the past few years, otologists have been seeing an increasing number of patients with vestibular disorders due to migraine-associated vestibulopathy. This article reviews some of the latest developments in the understanding of this disease process, specifically its incidence, symptoms, diagnosis, and treatment.


RESULTS
Migraine-associated vestibular symptoms may include episodic true vertigo, movement-provoked dysequilibrium, imbalance/unsteadiness, and complaints of lightheadedness. The pathophysiology of migraine-associated vestibulopathy is not completely understood; however, both peripheral and central deficits have been observed. Although the International Headache Society classification does not include migraine-associated vestibulopathy as a subclassification of migraine, there is emerging evidence to support this development, which should then lead toward improved diagnosis and treatment. Currently, migraine-associated vestibulopathy is still considered a diagnosis of exclusion.


CONCLUSIONS
Treatment of migraine-associated vestibulopathy is effective and includes lifestyle changes, such as reducing triggers that increase susceptibility to migraines (e.g. stress, poor diet, nicotine, or irregular sleep patterns), prophylactic and abortive medications, vestibular therapy, or a combination of these. Further research is needed to better understand migraine-associated vestibulopathy and improve treatment.
Honaker
Julie
J
Division of Audiology, Mayo Clinic, Rochester, Minnesota, USA.
Samy
Ravi N
RN
D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D015995:Prevalence; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015837:Vestibular Diseases / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D014724:Vestibular Function Tests